Russell Investments Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140M | Sell |
|
|||||
|
2025
Q1 | $164M | Buy |
|
|||||
|
2024
Q4 | $96.3M | Buy |
|
|||||
|
2024
Q3 | $107M | Sell |
|
|||||
|
2024
Q2 | $122M | Sell |
|
|||||
|
2024
Q1 | $116M | Sell |
|
|||||
|
2023
Q4 | $119M | Sell |
|
|||||
|
2023
Q3 | $124M | Sell |
|
|||||
|
2023
Q2 | $127M | Sell |
|
|||||
|
2023
Q1 | $121M | Buy |
|
|||||
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $94M | Buy |
|
|||||
|
2022
Q2 | $85M | Sell |
|
|||||
|
2022
Q1 | $88.1M | Buy |
|
|||||
|
2021
Q4 | $66.5M | Buy |
|
|||||
|
2021
Q3 | $54.4M | Sell |
|
|||||
|
2021
Q2 | $69.4M | Buy |
|
|||||
|
2021
Q1 | $41.9M | Sell |
|
|||||
|
2020
Q4 | $58.3M | Sell |
|
|||||
|
2020
Q3 | $69.6M | Sell |
|
|||||
|
2020
Q2 | $74.9M | Buy |
|
|||||
|
2020
Q1 | $41.3M | Buy |
|
|||||
|
2019
Q4 | $22.7M | Buy |
|
|||||
|
2019
Q3 | $9.27M | Sell |
|
|||||
|
2019
Q2 | $30.5M | Sell |
|
|||||
|
2019
Q1 | $41.2M | Sell |
|
|||||
|
2018
Q4 | $37.9M | Sell |
|
|||||
|
2018
Q3 | $45.2M | Buy |
|
|||||
|
2018
Q2 | $20.8M | Sell |
|
|||||
|
2018
Q1 | $25.9M | Buy |
|
|||||
|
2017
Q4 | $19.2M | Buy |
|
|||||
|
2017
Q3 | $18.4M | Sell |
|
|||||
|
2017
Q2 | $26.4M | Buy |
|
|||||
|
2017
Q1 | $10.6M | Buy |
|
|||||
|
2016
Q4 | $5.46M | Buy |
|